New funding supports roll out of Early Access Programme for SpectroSens real-time monitoring technology

Romsey, UK — Stratophase, a specialist in real-time chemical and biochemical measurement and detection, has started the new year in style by securing £2.5m follow-on funding from existing investor East Hill Management. Commenting on the funding, Dr Richard Williams, CEO of Stratophase said, “These are exciting times for Stratophase. We are initiating a SpectroSens Early Access Programme in key markets and are actively seeking strategic partner organisations with the intention of leveraging this widely applicable technology into multiple end markets”. The additional investment will enable the company to roll out their SpectroSens real-time monitoring technology in target markets. The roll out will be supported by recruitment of key staff and a move to larger premises.

Bringing together proven science from the telecoms, optics and biotech industries, the SpectroSens optical microchip platform technology is being developed for a number of applications in process measurement and bio-detection. Target applications to date include real-time in-line monitoring of pharmaceutical manufacturing (both small molecule and bio-pharmaceuticals), bio-fuel production, bio-detection for security and military defence and point-of-care diagnostics. The SpectroSens system is currently being trialled by several major organisations including a top tier multinational pharmaceutical company and the UK military.

For further information about Stratophase and the SpectroSens system, please visit www.stratophase.com.

About Stratophase:

Stratophase is a VC-funded spin-out from the University of Southampton in the UK. Its unique SpectroSens technology is an optical microchip sensor which measures chemical processes and detects biological targets. This core optical measurement technology can be realised in a vast array of sensing heads, offering a wide variety of system configurations applicable to a broad spectrum of industries including chemical and biochemical production as well as biological detection.

The Stratophase team, guided by CEO Dr Richard Williams, includes the original inventors of the SpectroSens technology as well as senior managers with a many years of industry experience.

About East Hill Management Company

East Hill Management Company is a VC fund based in Providence, R.I. USA. It has a number of investments in technology based University spinout companies in the UK.